The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
The pharmacological management of childhood anxiety disorders: a review
Abstract
Rationale Pediatric anxiety is a prevalent psychiatric disorder that may have important implications for school, social, and academic function. Psychopharmacological approaches to the treatment of pediatric anxiety have expanded over the past 20 years and increasing empirical evidence helps guide current clinical practice.Objective To review studies which examine the pharmacological treatment of pediatric anxiety disorders, including obsessive-compulsive disorder and to summarize treatment implications.Methods All relevant studies were searched using MEDLINE and PsycINFO search engines, supplemented by a manual bibliographical search; studies published between 1985 and 2006 that met inclusion criteria were examined.Results This article provides a systematic review of the psychopharmacological treatment of pediatric anxiety disorders based on available empirical evidence, with a focus on randomized controlled trials. General treatment principles and pharmacological management of specific pediatric anxiety disorders are also reviewed.Conclusion There is good evidence to support the efficacy of several pharmacological agents including the selective serotonin reuptake inhibitors to treat pediatric anxiety and obsessive-compulsive disorder, although there are still many unanswered questions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reinblatt and Riddle [41] summarized the literature about pharmacological management of childhood anxiety disorders, finding that paroxetine is effective for children and adolescents dealing with SAD [42].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“Overall, paroxetine was found to be significantly more effective than placebo in reducing the severity of SAD symptoms.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“The most prevalent observed side effects of paroxetine were insomnia, decreased appetite and vomiting.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“The results showed that the paroxetine group had a significantly higher response rate, as measured by the Clinical Global Impression-Improvement scale (CGI) [47], compared to the placebo group.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“Furthermore, the reduction of symptoms through pharmacotherapy can lead to more functional behaviors, particularly in interpersonal processes, such as decreased avoidance and reduced social distress [27,42].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Treating anxiety disorders in children: Results of a randomized clinical trial.
Kendall, P. C. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.1.100 · Cited by 1,376
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Research works printed but not linked: 3
- American Medical Association (2001) International classification of diseases, 9th revision, clinical modification physician ICD-9-CM, 2002, vol 1 and 2. AMA Press, Chicago, IL (color-coded, illustrated, annotated)
- Labellarte M, Ginsburg GS (2003) Anxiety disorders. In: Martin A, Scahill L, Charney D et al (eds) Pediatric psychopharmacology: principles and practice. Oxford University Press, New York, pp 496–510
- Viswanathan R, Paradis C (1991) Treatment of cancer phobia with fluoxetine. Am J Psychiatry 148:1090
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Assessment and Treatment of Anxiety Disorders in Children and Adolescents
Wehry, A. M., Beesdo-Baum, K., Hennelly, M. M., Connolly, S. D., & Strawn, J. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0591-z · Cited by 294
MCCORMICK, C., SMITH, C., & MATHEWS, I. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.005 · Cited by 278
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
Fear and missing out: Youth anxiety and functional outcomes.
Swan, A. J., & Kendall, P. C. (2016) · Clinical Psychology: Science and Practice · doi:10.1111/cpsp.12169 · Cited by 198
Metadata
- Authors
- Reinblatt, S. P., & Riddle, M. A.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Reinblatt, Shauna P.
- Venue
- Psychopharmacology
- Published
- 2007-01-05
- Volume
- 191
- Issue
- 1
- Pages
- 67-86
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2108623420
- Cited by
- 67
- References
- 152
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 8
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- childhood anxiety disorders, pharmacotherapy, obsessive-compulsive disorder, selective serotonin reuptake inhibitors, children, randomized controlled trials, treatment efficacy
- MeSH terms
- Adolescent, Psychology, Adolescent, Antidepressive Agents, Tricyclic, Anxiety Disorders, Child, Psychology, Child, Drug Administration Schedule, Drug Resistance, Humans, Mutism, Obsessive-Compulsive Disorder, Phobic Disorders, Stress Disorders, Post-Traumatic, Anti-Anxiety Agents, Panic Disorder, Treatment Outcome, Treatment Failure, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The pharmacological management of childhood anxiety disorders: a review. https://app.cochat.ai/papers/10.1007/s00213-006-0644-4
- The paper
- Reinblatt, S. P., & Riddle, M. A. (2007). The pharmacological management of childhood anxiety disorders: a review. Psychopharmacology. https://doi.org/10.1007/s00213-006-0644-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.